Fertility Test Market Trends

  • Report ID: 3231
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Fertility Test Market Trends

Growth Drivers

  • Higher Number of Women Suffering with PCOD & Obesity One of the most prevalent but manageable reasons of infertility in women is PCOS. The hormonal imbalance in PCOS patients prevents the development and release of eggs from the ovaries
  • PCOS is one of the most common causes of female infertility, affecting 6% to 12% totaled to 5 million women of reproductive age in the United States.
  • Rising Infertility Cases - According to the National Library of Medicine, 15% of couples worldwide struggle with infertility. Around 20–30% of cases of infertility are caused by males, who also contribute 50% overall.
  • Increase in the Mean Age of First Motherhood- By the end of 2019, the average age of women experiencing their first pregnancy grew from 29 to 30 internationally, according to figures from the OECD Family Database. The only OECD nation with a mean average age of 28 or less is Mexico.
  • Higher Consumption of Alcohol, and Tobacco Consumption- Adult drug, alcohol, and tobacco use has increased, which is attributed to busy lifestyles and environmental changes. More than one-third of all male adults globally use tobacco, and over 30% of women of reproductive age smoke, according to BioMed Central Ltd. Smoking has, on average, raised the chance of infertility by 60%. Owing to the alteration in their hormonal levels, both men and women who take substances like marijuana, cocaine, and performance-enhancing drugs likely to have problems getting pregnant.
  • Better Funding and Insurance Coverage has Increased- The frequency of IVF operations has increased as a result of government assistance in the form of money and insurance coverage across several nations worldwide. Singapore has the most expensive IVF procedures, with expenses ranging from USD 10,000 to USD 15,000 USD per cycle, however the Medicare System covers roughly 95% of the cost, according to a National Library of Medicine report.

Challenges

  • Social Stigma Associated with Fertility Tests in Several Countries
  • Lack of Awareness about Fertility Test in Rural Areas - The lack of accuracy in urine-based monitoring of ovulation, can lead to faulty track of fertile window, and if a couple is trying to conceive, they might miss a crucial period of ovulation. The accuracy can occur due to surge of luteinizing hormone in women who is taking the test, which gives false alarm. Therefore, inaccuracy can affect the growth of fertility test market.
  • Unproven Accuracy of Urine-Based Ovulation Monitoring

Fertility Test Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

8.3%

Base Year Market Size (2024)

USD 588.81 million

Forecast Year Market Size (2037)

USD 1.67 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3231
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fertility test is evaluated at USD 628.38 million.

The fertility test market size was valued at USD 588.81 million in 2024 and is poised to exceed USD 1.67 billion by the end of 2037, expanding at over 8.3% CAGR during the forecast period i.e., between 2025-2037. Rising instances of infertility in both males and females, rising pervasion of PCOD, and rise in the average age of first time motherhood will boost the market growth.

North America industry is expected to hold largest revenue share by 2037, driven by rise in the cases of infertility in the region.

The major players in the market include Swiss Precision Diagnostics, Legacy, Inc., Dadi Inc., Everlywell, Inc., Fertility Focus, ExSeed Health, Geratherm Medical, VirtualExpo, AdvaCare Pharma, Valley Electronics AG.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample